buserelin has been researched along with Bone Diseases, Metabolic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, E; Goulding, A; Stapley, S | 1 |
| Gold, E; Goulding, A | 3 |
| Asai, M; Hasegawa, H; Muramoto, A; Tanaka, F; Yamamori, I | 1 |
| Feng, W; Gold, E; Goulding, A | 1 |
| Fisher, L; Goulding, A | 2 |
8 other study(ies) available for buserelin and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Tamoxifen and norethisterone: effects on plasma cholesterol and total body calcium content in the estrogen-deficient rat.
Topics: Animals; Bone Diseases, Metabolic; Buserelin; Calcium; Cholesterol; Estradiol; Estrogens; Female; Norethindrone; Rats; Tamoxifen | 1994 |
Flutamide-mediated androgen blockade evokes osteopenia in the female rat.
Topics: Androgens; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Buserelin; Female; Flutamide; Hydroxyproline; Organ Size; Rats; Rats, Wistar; Uterus | 1993 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |
Prevention of premenstrual exacerbation of hereditary coproporphyria by gonadotropin-releasing hormone analogue.
Topics: Adult; Bone Diseases, Metabolic; Buserelin; Estrogens; Female; Humans; Japan; Menstrual Cycle; Porphyrias; Porphyrins | 1999 |
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus | 1992 |
Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Clomiphene; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Rats; Rats, Inbred Strains; Uterus | 1991 |
17 beta-estradiol protects rats from osteopenia associated with administration of the luteinising hormone releasing hormone (LHRH) agonist, buserelin.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Calcium Radioisotopes; Estradiol; Female; Hydroxyproline; Rats | 1991 |
A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Estradiol; Estrogens; Female; Organ Size; Ovariectomy; Rats; Uterus | 1989 |